Biohaven Pharmaceutical

+$0.25 (+0.24%) As of 3:35 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BHVN and other ETFs, options, and stocks.

About BHVN

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders.

CEO
Vladimir Coric
Employees
825
Headquarters
New Haven, Connecticut
Founded
2013

BHVN Key Statistics

Market cap
6.90B
Price-Earnings ratio
—
Dividend yield
—
Average volume
598.06K
High today
$105.86
Low today
$103.54
Open price
$103.85
Volume
32.05K
52 Week high
$151.51
52 Week low
$62.57

BHVN News

MarketWatchDec 6

Biohaven Pharma Names CEO Vlad Coric as Chairman, Names Matthew Buten CFO

By Michael Dabaie Biohaven Pharmaceutical Holding Co. Ltd. named its chief executive to the role of chairman and appointed a new chief financial officer. The

BHVN Earnings

-$2.97
-$1.98
-$0.99
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure